Germany
Japan
United Kingdom
China
Recombinant Anti-Fc gamma receptor III (Clone 3G8)
| Applications | FC, IHC, IP |
| Reactivities | Chimpanzee, Human, Macaque, Marmoset, Monkey, Baboon, Cynomolgus |
| Conjugation | Unconjugated |
Primary Antibodies
View as table DownloadRecombinant Anti-CD131 (Clone BION-1)
| Applications | Bl, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-10 (Clone 9D7)
| Applications | ELISA, IF, IHC, IP, Neutralize |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-PD-1H (Clone mam82)
| Applications | ELISA, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Tim-3 (Clone 2C12)
| Applications | Bl, FC, IF, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Tim-4 (Clone 5G3)
| Applications | Bl, ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Tim-4 (Clone 3A1)
| Applications | Bl, ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-RAGE (Clone 2A11)
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-RAP (Clone 7F1)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD53 (Clone HD77)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Tetraspanin 1 (Clone 4/12)
| Applications | ELISA, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD31 (Clone BAG-85D10)
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD41 (Clone BAG 75E5)
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD10 (Clone FR4D11)
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD1a (Clone CBT6)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD63 (Clone NK-1-C3)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD8 (Clone RIV11)
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD74 (Clone LN-2)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CD81 (Clone 1.3.3.22)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-Cytokeratin 7 (Clone OV-TL 12/30)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-4-1BB (Clone 4B4-1-1)
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone HMFG1 (1.10.F3))
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone PAM4)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Applications
- IHC
Isotypes
- IgG1, kappa
Clonalities
- Monoclonal
Filter by
Category
Target Symbol
- CD276 (5)
- LAG3 (5)
- CD4 (3)
- CD68 (3)
- CD81 (3)
- EGFR (3)
- EPCAM (3)
- MMP9 (3)
- VEGFA (3)
- WT1 (3)
- BIRC5 (2)
- CD19 (2)
- CD1A (2)
- CD28 (2)
- CD52 (2)
- CD63 (2)
- CD8A (2)
- CEA (2)
- DNMT1 (2)
- ENO2 (2)
- FN1 (2)
- IL2RA (2)
- KRT7 (2)
- LEY (2)
- MMP2 (2)
- MUC1 (2)
- MYOG (2)
- PECAM1 (2)
- POU2F2 (2)
- TAG72 (2)
- TIMD4 (2)
- TIMP1 (2)
- TNFRSF8 (2)
- TP73 (2)
- ACAN (1)
- ACPP (1)
- ACTC1 (1)
- ACTIN (1)
- AGER (1)
- AOC3 (1)
- APP (1)
- ARNT (1)
- ATF6 (1)
- ATP1A1 (1)
- BACE2 (1)
- BAX (1)
- BCL2 (1)
- BCLAF1 (1)
- CASP1 (1)
- CASP3 (1)
- CCL20 (1)
- CCL8 (1)
- CD16 (1)
- CD2 (1)
- CD34 (1)
- CD37 (1)
- CD3E (1)
- CD40 (1)
- CD53 (1)
- CD74 (1)
- CD79A (1)
- CDKN1B (1)
- CHGA (1)
- CHUK (1)
- CLEC4M (1)
- CNN1 (1)
- COL2A1 (1)
- CSF2RB (1)
- CSPG4 (1)
- CYP1A1 (1)
- CYP1A2 (1)
- CYP26B1 (1)
- CYP26C1 (1)
- CYP2A6 (1)
- CYP3A4 (1)
- CYP3A5 (1)
- CYP3A7 (1)
- CYP4A11 (1)
- CYP4F11 (1)
- CYP4V2 (1)
- CYP4Z1 (1)
- CYP51A1 (1)
- DES (1)
- DMD (1)
- DNMT3A (1)
- DSRNA (1)
- EBI3 (1)
- ERBB2 (1)
- FCER2 (1)
- FCGR2B (1)
- FLI1 (1)
- GAST (1)
- GH1 (1)
- GNL3 (1)
- GRK2 (1)
- HAVCR2 (1)
- IGM (1)
- IL10 (1)
- IL17RA (1)
- IL4 (1)
Reactivities
- Human (209)
- Mouse (49)
- Rat (36)
- Bovine (8)
- Monkey (6)
- Primate (6)
- Canine (5)
- Guinea Pig (4)
- Sheep (4)
- Cow (3)
- Hamster (3)
- Porcine (3)
- Rabbit (3)
- Xenopus (3)
- Zebrafish (3)
- Chicken (2)
- Chimpanzee (2)
- Drosophila (2)
- Feline (2)
- Goat (2)
- Pig (2)
- Baboon (1)
- C. elegans (1)
- Cynomolgus (1)
- Dog (1)
- Equine (1)
- Ferret (1)
- Macaque (1)
- Marmoset (1)
- Plant (1)
- Virus (1)
Antibody Hosts
Conjugates
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (94)
- Transmembrane (51)
- ES Cell Differentiation/IPS (17)
- Transcription Factors (16)
- Secreted Protein (13)
- P450 (12)
- Protease (11)
- Stem cell - Pluripotency (8)
- Protein Kinase (5)
- Adult stem cells (4)
- Cancer stem cells (2)
- Phosphatase (2)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Pathways in cancer (20)
- Metabolic pathways (13)
- Cell adhesion molecules (CAMs) (10)
- Retinol metabolism (10)
- Bladder cancer (9)
- Cytokine-cytokine receptor interaction (9)
- Apoptosis (8)
- B cell receptor signaling pathway (8)
- Chemokine signaling pathway (8)
- MAPK signaling pathway (8)
- Prostate cancer (8)
- T cell receptor signaling pathway (8)
- NOD-like receptor signaling pathway (7)
- Neurotrophin signaling pathway (7)
- Toll-like receptor signaling pathway (7)
- Colorectal cancer (6)
- Cytosolic DNA-sensing pathway (6)
- Epithelial cell signaling in Helicobacter pylori infection (6)
- Leukocyte transendothelial migration (6)
- Lysosome (6)
- Pancreatic cancer (6)
- RIG-I-like receptor signaling pathway (6)
- Small cell lung cancer (6)
- Adipocytokine signaling pathway (5)
- Chronic myeloid leukemia (5)
- Drug metabolism - cytochrome P450 (5)
- Metabolism of xenobiotics by cytochrome P450 (5)
- Acute myeloid leukemia (4)
- Amyotrophic lateral sclerosis (ALS) (4)
- Drug metabolism - other enzymes (4)
- Focal adhesion (4)
- GnRH signaling pathway (4)
- Hematopoietic cell lineage (4)
- Linoleic acid metabolism (4)
- Natural killer cell mediated cytotoxicity (4)
- p53 signaling pathway (4)
- Cysteine and methionine metabolism (3)
- Gap junction (3)
- Primary immunodeficiency (3)
- Renal cell carcinoma (3)
- Vascular smooth muscle contraction (3)
- Viral myocarditis (3)
- Adherens junction (2)
- Alzheimer's disease (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Caffeine metabolism (2)
- Dilated cardiomyopathy (2)
- Endocytosis (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Glioma (2)
- Glycolysis / Gluconeogenesis (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Insulin signaling pathway (2)
- Melanoma (2)
- Non-small cell lung cancer (2)
- PPAR signaling pathway (2)
- RNA degradation (2)
- Regulation of actin cytoskeleton (2)
- Tryptophan metabolism (2)
- VEGF signaling pathway (2)
- Antigen processing and presentation (1)
- Arachidonic acid metabolism (1)
- Calcium signaling pathway (1)
- Cardiac muscle contraction (1)
- Complement and coagulation cascades (1)
- Dorso-ventral axis formation (1)
- Fatty acid metabolism (1)
- Fc epsilon RI signaling pathway (1)
- Huntington's disease (1)
- Jak-STAT signaling pathway (1)
- Long-term depression (1)
- Long-term potentiation (1)
- Melanogenesis (1)
- Parkinson's disease (1)
- Pathogenic Escherichia coli infection (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Ribosome (1)
- Starch and sucrose metabolism (1)
- Steroid biosynthesis (1)
- Tight junction (1)
- mTOR signaling pathway (1)